Brandon Roy-Garland, MD
Vascular Surgery · Denver, CONPI 1235454497
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Globus Medical accounts for 66.4% of it on its own, with 35 other manufacturers making up the rest. Among vascular surgery clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $597.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$126K
- Philips North America LLC$29K
- Cook Incorporated$12K
- Terumo Medical Corporation$5K
- Medtronic$3K
- Angiodynamics, Inc.$3K
- plus $12K from 30 others
What the payments were for
- Consulting fees$86,68846%
- Speaking & faculty fees$79,35042%
- Travel & lodging$7,9424%
- Food & beverage$13,2867%
- Other$2,7151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 53 | $126,108 |
| Philips North America LLC | 25 | $28,952 |
| Cook Incorporated | 2 | $12,100 |
| Terumo Medical Corporation | 25 | $4,985 |
| Medtronic(2 entities) | 41 | $3,064 |
| Angiodynamics, Inc. | 4 | $2,752 |
| Endologix LLC | 12 | $2,725 |
| W. L. Gore & Associates, Inc. | 28 | $2,565 |
| Cook Medical LLC | 26 | $1,531 |
| Boston Scientific | 12 | $876 |
| Silk Road Medical, Inc. | 6 | $763 |
| Bolton Medical Inc | 11 | $641 |
| Abbott | 9 | $514 |
| Inari Medical, Inc. | 7 | $346 |
| Cardiovascular Systems Inc. | 6 | $286 |
| Lemaitre Vascular, Inc. | 8 | $278 |
| Cvrx, Inc. | 3 | $261 |
| Sanara Medtech Inc. | 4 | $214 |
| Johnson & Johnson | 8 | $121 |
| Tactile Systems Technology Inc | 3 | $117 |
| Viiv Healthcare Company | 1 | $114 |
| Mimedx Group, Inc. | 2 | $98 |
| Veryan Medical Incorporated | 1 | $77 |
| Surmodics, Inc. | 2 | $75 |
| Integra Lifesciences Corporation | 2 | $68 |
| Artivion, Inc. | 3 | $54 |
| Penumbra, Inc. | 1 | $49 |
| Bard Peripheral Vascular, Inc. | 2 | $42 |
| Getinge USA Sales, LLC | 2 | $35 |
| Smith+Nephew | 1 | $33 |
| Pfizer | 2 | $31 |
| Argon Medical Devices, Inc. | 2 | $31 |
| Cordis US CORP. | 1 | $29 |
| Acell, Inc. | 1 | $16 |
| Aroa Biosurgery Incorporated | 1 | $14 |
| Baudax Bio Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MARS 3VL$32,952
- MARS Anterior Retractor$29,075
- (9520) IGT Devices Undivided$25,075
- Excelsius - GPS$22,013
- Zenith Spiral-Z$10,000
- Excelsius Robotics System$8,361
- ExcelsiusGPS Robotic Navigation System$6,175
- ALIF$6,071
- ELSA$5,500
- IGT Devices Und$3,600
- MARS 3V/3VL$3,500
- Azur CX Detachable$3,386
- Auryon Laser System 100-120 Vac$2,715
- MARS 3VL Retractor$2,486
- Zenith$2,203
- Valiant Navion$1,688
- GORE TAG Thoracic Endoprosthesis$1,410
- Ovation$1,137
- Ovation iX Iliac Stent Graft$979
- AngioSeal$888
How this compares
$189,981 in reported general payments places this provider in the 95th percentile of 66 vascular surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $21,273 |
| XareltoRivaroxaban | 20 | $20,579 |
| Prasugrel Hcl | 22 | $1,419 |
| ClopidogrelClopidogrel Bisulfate | 43 | $309 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $31 | $21,27328 claims |
| Johnson & JohnsonXarelto | $121 | $20,57920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 66 vascular surgery providers in Colorado.
Other vascular surgery in Denver
- Lisa BennettDenver$30K
- Stephen AnnestDenver$28K
- Omar MubarakDenver$22K
- Alexander LeungDenver$21K
- Alan SynnDenver$16K
- Charles FoxDenver$11K
- Timothy ChiltonDenver$10K
- Barbara MelendezDenver$7K
- Rebecca UrDenver$4K
- Eric WeinsteinDenver$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.